SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-175492
Filing Date
2021-05-27
Accepted
2021-05-27 17:03:04
Documents
51
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 6-K d167568d6k.htm 6-K 15537
2 EX-99.1 d167568dex991.htm EX-99.1 250644
3 EX-99.2 d167568dex992.htm EX-99.2 124395
4 EX-99.3 d167568dex993.htm EX-99.3 38906
11 GRAPHIC g167568g0527083011749.jpg GRAPHIC 3289
12 GRAPHIC g167568g58j66.jpg GRAPHIC 37231
  Complete submission text file 0001193125-21-175492.txt   2484196

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20210331.xml EX-101.INS 453679
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20210331.xsd EX-101.SCH 34202
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20210331_cal.xml EX-101.CAL 35349
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20210331_def.xml EX-101.DEF 95804
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20210331_lab.xml EX-101.LAB 231293
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20210331_pre.xml EX-101.PRE 170929
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 21973863
SIC: 2834 Pharmaceutical Preparations